Treatment with nivolumab (Opdivo) had limited benefit in patients with multiple myeloma (MM) or non-Hodkin lymphoma (NHL) ...

Notably, the endogenous retrovirus they studied appears to switch on genes in what is known as the MAP-kinase pathway, a famed cellular pathway that is adversely rewired in many cancers. Existing ...

The FDA approved a new treatment for adults with endogenous hypercortisolemia related to Cushing's syndrome, Xeris Biopharma announced late last week. The oral drug levoketoconazole (Recorlev) is ...